Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17207415rdf:typepubmed:Citationlld:pubmed
pubmed-article:17207415lifeskim:mentionsumls-concept:C0031336lld:lifeskim
pubmed-article:17207415lifeskim:mentionsumls-concept:C0013058lld:lifeskim
pubmed-article:17207415lifeskim:mentionsumls-concept:C0444626lld:lifeskim
pubmed-article:17207415lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:17207415lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:17207415lifeskim:mentionsumls-concept:C0036397lld:lifeskim
pubmed-article:17207415lifeskim:mentionsumls-concept:C1553890lld:lifeskim
pubmed-article:17207415lifeskim:mentionsumls-concept:C1710028lld:lifeskim
pubmed-article:17207415pubmed:issue3lld:pubmed
pubmed-article:17207415pubmed:dateCreated2007-1-8lld:pubmed
pubmed-article:17207415pubmed:abstractTextThe commentary seeks to provide a brief history and perspective on the importance of crystal forms of pharmaceuticals as a means of achieving performance criteria. The expanding scope of crystal form selection, emergence of crystal engineering in pharmaceutical science and pharmaceutical co-crystals are topics of this brief review.lld:pubmed
pubmed-article:17207415pubmed:languageenglld:pubmed
pubmed-article:17207415pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17207415pubmed:citationSubsetIMlld:pubmed
pubmed-article:17207415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17207415pubmed:statusMEDLINElld:pubmed
pubmed-article:17207415pubmed:issn1482-1826lld:pubmed
pubmed-article:17207415pubmed:authorpubmed-author:PetersonMatth...lld:pubmed
pubmed-article:17207415pubmed:authorpubmed-author:ZaworotkoMich...lld:pubmed
pubmed-article:17207415pubmed:authorpubmed-author:AlmarssonOrnOlld:pubmed
pubmed-article:17207415pubmed:authorpubmed-author:HickeyMagali...lld:pubmed
pubmed-article:17207415pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17207415pubmed:volume9lld:pubmed
pubmed-article:17207415pubmed:ownerNLMlld:pubmed
pubmed-article:17207415pubmed:authorsCompleteYlld:pubmed
pubmed-article:17207415pubmed:pagination317-26lld:pubmed
pubmed-article:17207415pubmed:meshHeadingpubmed-meshheading:17207415...lld:pubmed
pubmed-article:17207415pubmed:meshHeadingpubmed-meshheading:17207415...lld:pubmed
pubmed-article:17207415pubmed:meshHeadingpubmed-meshheading:17207415...lld:pubmed
pubmed-article:17207415pubmed:meshHeadingpubmed-meshheading:17207415...lld:pubmed
pubmed-article:17207415pubmed:year2006lld:pubmed
pubmed-article:17207415pubmed:articleTitleExpanding the scope of crystal form evaluation in pharmaceutical science.lld:pubmed
pubmed-article:17207415pubmed:affiliationTransForm Pharmaceuticals Inc. Lexington, MA 02421, USA. mpeterson@transformpharma.comlld:pubmed
pubmed-article:17207415pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17207415pubmed:publicationTypeReviewlld:pubmed